Lista de obras - Jonathan Kay - Dominio Público Uruguay

2010 Rheumatoid arthritis classification criteria: An American College of Rheumatology/European League Against Rheumatism collaborative initiative

scholarly article by Daniel Aletaha et al published 10 August 2010 in Arthritis and Rheumatism

2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative

artículo científico publicado en 2010

A 'wind of change' to biosimilars: The NOR-SWITCH trial and its extension

artículo científico publicado en 2019

A Fifty-Two-Week, Randomized, Placebo-Controlled Trial of Certolizumab Pegol in Nonradiographic Axial Spondyloarthritis

scientific article published on 28 May 2019

A rheumatology-specific informatics-based application with a disease activity calculator

artículo científico publicado en 2009

ACR/EULAR 2010 rheumatoid arthritis classification criteria

artículo científico publicado en 2012

Activation of CD4 cells by fibronectin and anti-CD3 antibody. A synergistic effect mediated by the VLA-5 fibronectin receptor complex

artículo científico publicado en 1989

Advanced glycation endproducts and osteoarthritis

artículo científico publicado en 2003

Aminoguanidine inhibits advanced glycation end products formation on beta2-microglobulin

artículo científico publicado en 1998

Are There Benefits and Risks to Biosimilars from a Patient Perspective?

scientific article published on 24 May 2019

Assessment of control of rheumatoid arthritis disease activity

artículo científico

Biosimilars to treat inflammatory arthritis: the challenge of proving identity

artículo científico publicado en 2013

Biosimilars: a regulatory perspective from America ⬇️

artículo científico publicado el 12 de mayo de 2011

Bone damage in rheumatoid arthritis: mechanistic insights and approaches to prevention

artículo científico publicado en 2010

Brief Report: Biosimilar Uptake in the Academic and Veterans Health Administration Settings: Influence of Institutional Incentives

scientific article published on 06 April 2020

Case 35-2004

Case 37-2009

artículo científico publicado en 2009

Case 6-2008

Case records of the Massachusetts General Hospital. Case 31-2005. A 60-year-old man with skin lesions and renal insufficiency

artículo científico publicado en 2005

Case records of the Massachusetts General Hospital. Case 39-2006. A 24-year-old woman with systemic lupus erythematosus, seizures, and right arm weakness

artículo científico publicado en 2006

Case records of the Massachusetts General Hospital. Case 4-2006. A 79-year-old woman with myalgias, fatigue, and shortness of breath

artículo científico publicado en 2006

Changes in selected haematological parameters associated with JAK1/JAK2 inhibition observed in patients with rheumatoid arthritis treated with baricitinib

artículo científico publicado en 2020

Churg-strauss syndrome with diffuse gastrointestinal involvement

artículo científico publicado en 1996

Clinical disease activity and acute phase reactant levels are discordant among patients with active rheumatoid arthritis: acute phase reactant levels contribute separately to predicting outcome at one year

scientific article published on 03 February 2014

Clinical trial and 'real-world' data support switching from a bio-originator to its biosimilar

artículo científico publicado en 2019

Clinical trials of biosimilars should become more similar

artículo científico publicado en 2016

Consensus-based recommendations for the use of biosimilars to treat rheumatological diseases

artículo científico publicado en 2017

Controversies in Rheumatology

Current status of nephrogenic systemic fibrosis

artículo científico publicado en 2014

Cutaneous changes of nephrogenic systemic fibrosis: predictor of early mortality and association with gadolinium exposure

artículo científico publicado en 2007

Dermatomyositis update

artículo científico publicado en 1995

Development of gastrointestinal beta2-microglobulin amyloidosis correlates with time on dialysis

artículo científico publicado en 1998

Diabetes mellitus and insulin resistance in patients with rheumatoid arthritis: risk reduction in a chronic inflammatory disease

artículo científico publicado en 2011

E-selectin, interleukin 18, serum amyloid a, and matrix metalloproteinase 9 are associated with clinical response to golimumab plus methotrexate in patients with active rheumatoid arthritis despite methotrexate therapy

artículo científico publicado en 2009

Erratum to: Treating rheumatoid arthritis to target: an international initiative

artículo científico publicado en 2011

Evolution of treatment for rheumatoid arthritis

artículo científico publicado en 2012

Examining Treatment Decision-Making Among Patients With Axial Spondyloarthritis: Insights From a Conjoint Analysis Survey

artículo científico publicado en 2020

Fibrosis-Associated Single-Nucleotide Polymorphisms in TGFB1 and CAV1 Are Not Associated With the Development of Nephrogenic Systemic Fibrosis

article

From other pages

artículo científico publicado en 1997

Gadolinium and nephrogenic systemic fibrosis: the evidence of things not seen

article

Gadolinium and systemic fibrosis: guilt by association

article

Gadolinium-Induced Fibrosis

artículo científico publicado en 2016

Gadolinium-based compounds induce NLRP3-dependent IL-1β production and peritoneal inflammation

artículo científico publicado en 2014

Golimumab 3-year safety update: an analysis of pooled data from the long-term extensions of randomised, double-blind, placebo-controlled trials conducted in patients with rheumatoid arthritis, psoriatic arthritis or ankylosing spondylitis

artículo científico publicado en 2013

Golimumab in patients with active rheumatoid arthritis after treatment with tumour necrosis factor alpha inhibitors (GO-AFTER study): a multicentre, randomised, double-blind, placebo-controlled, phase III trial

artículo científico publicado en 2009

Golimumab in patients with active rheumatoid arthritis despite treatment with methotrexate: A randomized, double-blind, placebo-controlled, dose-ranging study

article

Golimumab in patients with active rheumatoid arthritis who have previous experience with tumour necrosis factor inhibitors: results of a long-term extension of the randomised, double-blind, placebo-controlled GO-AFTER study through week 160

artículo científico publicado en 2012

Golimumab: A novel human anti-TNF-alpha monoclonal antibody for the treatment of rheumatoid arthritis, ankylosing spondylitis, and psoriatic arthritis.

artículo científico publicado en 2009

Health Canada/BIOTECanada Summit on regulatory and clinical topics related to subsequent entry biologics (biosimilars), Ottawa, Canada, 14 May 2012.

artículo científico publicado en 2012

Hematologic and immunologic abnormalities in anorexia nervosa.

artículo científico publicado en 1983

Identification and characterization of opsonic fibronectin in synovial fluids of patients with active rheumatoid arthritis

artículo científico publicado en 1991

Imatinib mesylate treatment of nephrogenic systemic fibrosis

artículo científico publicado en 2008

Incidence of nephrogenic systemic fibrosis after adoption of restrictive gadolinium-based contrast agent guidelines

artículo científico publicado en 2011

Insights into the efficacy of golimumab plus methotrexate in patients with active rheumatoid arthritis who discontinued prior anti-tumour necrosis factor therapy: post-hoc analyses from the GO-AFTER study

artículo científico publicado en 2013

Interaction between β2-microglobulin and advanced glycation end products in the development of dialysis related-amyloidosis

article

Isolation and characterization of beta-glucan receptors on human mononuclear phagocytes

artículo científico publicado en 1991

Methotrexate: the gold standard without standardisation.

artículo científico publicado en 2009

Musculoskeletal manifestations in β2 -microglobulin amyloidosis. Case discussion

article

Nephrogenic systemic fibrosis after gadopentetate dimeglumine exposure: case series of 36 patients

scientific article published on 25 August 2009

Nephrogenic systemic fibrosis: a gadolinium-associated fibrosing disorder in patients with renal dysfunction

artículo científico publicado en 2008

Nephrogenic systemic fibrosis: a new concern for rheumatologists

article

Nephrogenic systemic fibrosis: a pathologic study of autopsy cases

artículo científico publicado en 2009

Nephrogenic systemic fibrosis: a systemic fibrosing disease resulting from gadolinium exposure

artículo científico publicado en 2012

Nephrogenic systemic fibrosis: an epidemic of gadolinium toxicity

artículo científico publicado en 2008

Nephrogenic systemic fibrosis: clinicopathological definition and workup recommendations

artículo científico publicado en 2011

Non-crystalline and crystalline rheumatic disorders in chronic kidney disease

artículo científico publicado en 2008

Osteoarticular disorders of renal origin: disease-related and iatrogenic

Overcoming barriers to biosimilars in inflammatory arthritis

artículo científico publicado en 2020

Patient Concerns and Perceptions Regarding Biologic Therapies in Ankylosing Spondylitis: Insights From a Large-Scale Survey of Social Media Platforms

scientific article published on 01 February 2019

Performance characteristics of a dialysis-related amyloidosis questionnaire

artículo científico publicado en 1996

Physician ability to assess rheumatoid arthritis disease activity using an electronic medical record-based disease activity calculator

scientific article published on 01 April 2009

Preface

Prevalence of comorbidities in rheumatoid arthritis and evaluation of their monitoring: results of an international, cross-sectional study (COMORA).

artículo científico publicado en 2013

Quantitative assessment of dermal cellularity in nephrogenic systemic fibrosis: A diagnostic aid

scientific article published on 01 April 2011

Regression of lymphoproliferative disorder after treatment for hepatitis C virus infection in a patient with partial trisomy 3, Bcl-2 overexpression, and type II cryoglobulinemia

artículo científico publicado en 2002

Relapsing polychondritis

artículo científico publicado en 2013

Retrospective assessment of prevalence of nephrogenic systemic fibrosis (NSF) after implementation of a new guideline for the use of gadobenate dimeglumine as a sole contrast agent for magnetic resonance examination in renally impaired patients

artículo científico publicado en 2009

Rheumatic Manifestations of Diabetes Mellitus

article by Dorota Lebiedz-Odrobina et al published November 2010 in Rheumatic Diseases Clinics of North America

Rheumatoid arthritis: erosion defined: back to basics

artículo científico publicado en 2013

Rituximab biosimilars

artículo científico publicado en 2013

Sarilumab for the treatment of ankylosing spondylitis: results of a Phase II, randomised, double-blind, placebo-controlled study (ALIGN)

artículo científico publicado en 2014

Sensorineural hearing loss following imatinib (Gleevec) administration

artículo científico publicado en 2011

Synovial fluid eosinophilia in lyme disease

article

Systemic sclerosis without antinuclear antibodies or Raynaud's phenomenon: a multicentre study in the prospective EULAR Scleroderma Trials and Research (EUSTAR) database

artículo científico publicado en 2012

The "Treat to Target" Approach to Rheumatoid Arthritis

artículo científico publicado en 2019

The 2010 American College of Rheumatology/European League Against Rheumatism classification criteria for rheumatoid arthritis: Methodological Report Phase I

scholarly article by J. Funovits et al published 10 August 2010 in Annals of the Rheumatic Diseases

The 2010 American College of Rheumatology/European League Against Rheumatism classification criteria for rheumatoid arthritis: Phase 2 methodological report

artículo científico publicado en 2010

The Science Behind Biosimilars: Entering a New Era of Biologic Therapy

artículo científico publicado en 2018

The advent of biosimilar therapies in rheumatology—“O Brave New World”

The changing landscape of biosimilars in rheumatology

artículo científico publicado en 2016

The effect of golimumab on haemoglobin levels in patients with rheumatoid arthritis, psoriatic arthritis or ankylosing spondylitis

artículo científico publicado en 2013

The term 'non-radiographic axial spondyloarthritis' is much more important to classify than to diagnose patients with axial spondyloarthritis

artículo científico publicado en 2016

Tocilizumab combination therapy or monotherapy or methotrexate monotherapy in methotrexate-naive patients with early rheumatoid arthritis: 2-year clinical and radiographic results from the randomised, placebo-controlled FUNCTION trial

artículo científico publicado en 2017

Tocilizumab in early progressive rheumatoid arthritis: FUNCTION, a randomised controlled trial

artículo científico publicado en 2015

Treat-to-target (T2T) recommendations for gout

artículo científico publicado en 2016

Treating rheumatoid arthritis to target: an international initiative

artículo científico publicado en 2011

Unmet need in rheumatology: reports from the Targeted Therapies meeting 2018

scientific article published on 02 February 2019

Utility of high-resolution ultrasound for the diagnosis of dialysis-related amyloidosis

artículo científico publicado en 1992

Validation of a screening instrument for nephrogenic systemic fibrosis.

artículo científico publicado en 2013

Wegener's granulomatosis: is biologic therapy useful?

artículo científico publicado en 2006

β2-microglobulin modified with advanced glycation end products modulates collagen synthesis by human fibroblasts ⬇️

artículo científico publicado el 1 de mayo de 1998

Lista de obras de Jonathan Kay

2010 Rheumatoid arthritis classification criteria: An American College of Rheumatology/European League Against Rheumatism collaborative initiative

2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative

A 'wind of change' to biosimilars: The NOR-SWITCH trial and its extension

A Fifty-Two-Week, Randomized, Placebo-Controlled Trial of Certolizumab Pegol in Nonradiographic Axial Spondyloarthritis

A rheumatology-specific informatics-based application with a disease activity calculator

ACR/EULAR 2010 rheumatoid arthritis classification criteria

Activation of CD4 cells by fibronectin and anti-CD3 antibody. A synergistic effect mediated by the VLA-5 fibronectin receptor complex

Advanced glycation endproducts and osteoarthritis

Aminoguanidine inhibits advanced glycation end products formation on beta2-microglobulin

Are There Benefits and Risks to Biosimilars from a Patient Perspective?

Assessment of control of rheumatoid arthritis disease activity

Biosimilars to treat inflammatory arthritis: the challenge of proving identity

Biosimilars: a regulatory perspective from America ⬇️

Bone damage in rheumatoid arthritis: mechanistic insights and approaches to prevention

Brief Report: Biosimilar Uptake in the Academic and Veterans Health Administration Settings: Influence of Institutional Incentives

Case 35-2004

Case 37-2009

Case 6-2008

Case records of the Massachusetts General Hospital. Case 31-2005. A 60-year-old man with skin lesions and renal insufficiency

Case records of the Massachusetts General Hospital. Case 39-2006. A 24-year-old woman with systemic lupus erythematosus, seizures, and right arm weakness

Case records of the Massachusetts General Hospital. Case 4-2006. A 79-year-old woman with myalgias, fatigue, and shortness of breath

Changes in selected haematological parameters associated with JAK1/JAK2 inhibition observed in patients with rheumatoid arthritis treated with baricitinib

Churg-strauss syndrome with diffuse gastrointestinal involvement

Clinical disease activity and acute phase reactant levels are discordant among patients with active rheumatoid arthritis: acute phase reactant levels contribute separately to predicting outcome at one year

Clinical trial and 'real-world' data support switching from a bio-originator to its biosimilar

Clinical trials of biosimilars should become more similar

Consensus-based recommendations for the use of biosimilars to treat rheumatological diseases

Controversies in Rheumatology

Current status of nephrogenic systemic fibrosis

Cutaneous changes of nephrogenic systemic fibrosis: predictor of early mortality and association with gadolinium exposure

Dermatomyositis update

Development of gastrointestinal beta2-microglobulin amyloidosis correlates with time on dialysis

Diabetes mellitus and insulin resistance in patients with rheumatoid arthritis: risk reduction in a chronic inflammatory disease

E-selectin, interleukin 18, serum amyloid a, and matrix metalloproteinase 9 are associated with clinical response to golimumab plus methotrexate in patients with active rheumatoid arthritis despite methotrexate therapy

Erratum to: Treating rheumatoid arthritis to target: an international initiative

Evolution of treatment for rheumatoid arthritis

Examining Treatment Decision-Making Among Patients With Axial Spondyloarthritis: Insights From a Conjoint Analysis Survey

Fibrosis-Associated Single-Nucleotide Polymorphisms in TGFB1 and CAV1 Are Not Associated With the Development of Nephrogenic Systemic Fibrosis

From other pages

Gadolinium and nephrogenic systemic fibrosis: the evidence of things not seen

Gadolinium and systemic fibrosis: guilt by association

Gadolinium-Induced Fibrosis

Gadolinium-based compounds induce NLRP3-dependent IL-1β production and peritoneal inflammation

Golimumab 3-year safety update: an analysis of pooled data from the long-term extensions of randomised, double-blind, placebo-controlled trials conducted in patients with rheumatoid arthritis, psoriatic arthritis or ankylosing spondylitis

Golimumab in patients with active rheumatoid arthritis after treatment with tumour necrosis factor alpha inhibitors (GO-AFTER study): a multicentre, randomised, double-blind, placebo-controlled, phase III trial

Golimumab in patients with active rheumatoid arthritis despite treatment with methotrexate: A randomized, double-blind, placebo-controlled, dose-ranging study

Golimumab in patients with active rheumatoid arthritis who have previous experience with tumour necrosis factor inhibitors: results of a long-term extension of the randomised, double-blind, placebo-controlled GO-AFTER study through week 160

Golimumab: A novel human anti-TNF-alpha monoclonal antibody for the treatment of rheumatoid arthritis, ankylosing spondylitis, and psoriatic arthritis.

Health Canada/BIOTECanada Summit on regulatory and clinical topics related to subsequent entry biologics (biosimilars), Ottawa, Canada, 14 May 2012.

Hematologic and immunologic abnormalities in anorexia nervosa.

Identification and characterization of opsonic fibronectin in synovial fluids of patients with active rheumatoid arthritis

Imatinib mesylate treatment of nephrogenic systemic fibrosis

Incidence of nephrogenic systemic fibrosis after adoption of restrictive gadolinium-based contrast agent guidelines

Insights into the efficacy of golimumab plus methotrexate in patients with active rheumatoid arthritis who discontinued prior anti-tumour necrosis factor therapy: post-hoc analyses from the GO-AFTER study

Interaction between β2-microglobulin and advanced glycation end products in the development of dialysis related-amyloidosis

Isolation and characterization of beta-glucan receptors on human mononuclear phagocytes

Methotrexate: the gold standard without standardisation.

Musculoskeletal manifestations in β2 -microglobulin amyloidosis. Case discussion

Nephrogenic systemic fibrosis after gadopentetate dimeglumine exposure: case series of 36 patients

Nephrogenic systemic fibrosis: a gadolinium-associated fibrosing disorder in patients with renal dysfunction

Nephrogenic systemic fibrosis: a new concern for rheumatologists

Nephrogenic systemic fibrosis: a pathologic study of autopsy cases

Nephrogenic systemic fibrosis: a systemic fibrosing disease resulting from gadolinium exposure

Nephrogenic systemic fibrosis: an epidemic of gadolinium toxicity

Nephrogenic systemic fibrosis: clinicopathological definition and workup recommendations

Non-crystalline and crystalline rheumatic disorders in chronic kidney disease

Osteoarticular disorders of renal origin: disease-related and iatrogenic

Overcoming barriers to biosimilars in inflammatory arthritis

Patient Concerns and Perceptions Regarding Biologic Therapies in Ankylosing Spondylitis: Insights From a Large-Scale Survey of Social Media Platforms

Performance characteristics of a dialysis-related amyloidosis questionnaire

Physician ability to assess rheumatoid arthritis disease activity using an electronic medical record-based disease activity calculator

Preface

Prevalence of comorbidities in rheumatoid arthritis and evaluation of their monitoring: results of an international, cross-sectional study (COMORA).

Quantitative assessment of dermal cellularity in nephrogenic systemic fibrosis: A diagnostic aid

Regression of lymphoproliferative disorder after treatment for hepatitis C virus infection in a patient with partial trisomy 3, Bcl-2 overexpression, and type II cryoglobulinemia

Relapsing polychondritis

Retrospective assessment of prevalence of nephrogenic systemic fibrosis (NSF) after implementation of a new guideline for the use of gadobenate dimeglumine as a sole contrast agent for magnetic resonance examination in renally impaired patients

Rheumatic Manifestations of Diabetes Mellitus

Rheumatoid arthritis: erosion defined: back to basics